[1]张士跃,张 庆a,刘春来,等.脓毒症休克患者血脂水平动态监测对预测短期预后的价值研究[J].现代检验医学杂志,2024,39(04):72-75.[doi:10.3969/j.issn.1671-7414.2024.04.013]
　ZHANG Shiyue,ZHANG Qinga,LIU Chunlai,et al.Research of the Value of Dynamic Monitoring of Blood Lipid Levels in Septic Shock for Predicting Short-Term Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(04):72-75.[doi:10.3969/j.issn.1671-7414.2024.04.013]
点击复制

脓毒症休克患者血脂水平动态监测对预测短期预后的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年04期
页码:
72-75
栏目:
论著
出版日期:
2024-07-15

文章信息/Info

Title:
Research of the Value of Dynamic Monitoring of Blood Lipid Levels in Septic Shock for Predicting Short-Term Prognosis
文章编号:
1671-7414（2024）04-072-04
作者:
张士跃1; 张 庆2a; 刘春来1; 齐 兴2b
（1. 北京通州区中西医结合医院，北京 101199；2. 北京中医药大学东直门医院a. 重症监护室；b. 检验科，北京 100701）
Author(s):
ZHANG Shiyue1;  ZHANG Qing2a;  LIU Chunlai1;  QI Xing2b
（1. Department of Clinical Laboratory, the Tongzhou District Integrated Traditional Chinese and Western Medicine Hospital, Beijing 101199, China; 2a. Department of Intensive Care Unit; 2b. Department of Clinical Laboratory, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100701, China）
关键词:
脓毒症休克; 胆固醇; 高密度脂蛋白- 胆固醇
分类号:
R631；R446.112
DOI:
10.3969/j.issn.1671-7414.2024.04.013
文献标志码:
A
摘要:
目的 探讨血脂水平动态变化对脓毒症休克患者短期预后的预测价值。方法 选取2019 年3 月~2023 年7 月北京中医药大学东直门医院诊治的脓毒症休克患者107 例为研究对象。根据患者28 天生存结局分为生存组（n=76）和死亡组（n=31）。检测入院日（Day0），第4±1 天和第7±1 天的总胆固醇（total cholesterol，TC）、三酰甘油（triglyceride，TG）、高密度脂蛋白- 胆固醇（high density lipoprotein-cholesterol，HDL-C）和低密度脂蛋白- 胆固醇（low densitylipoprotein-cholesterol，LDL-C）水平。受试者工作特征（ROC）曲线用于分析血脂动态变化对脓毒症休克患者生存结局的预测价值。多因素COX 回归分析影响患者预后因素。结果 生存组入院日TC 和LDL-C 水平第4±1 天和第7±1天的TC，HDL-C 和LDL-C 水平均明显高于死亡组患者，差异具有统计学意义（Z=2.241 ~ 5.744，均P<0.05）。入院第一周HDL-C 和LDL-C 变化量[D(7±1) － D0] 预测生存结局的曲线下面积[AUC（95%CI）] 分别为0.775（0.685 ~0.850），0.646（0.547 ~ 0.736），最佳截断值为0.16mmol/L，0.28mmol/L；敏感度分别为70.97%，64.52%；特异度分别为82.89%，69.74%。多变量回归分析确定HDL-C 动态变化与预后不良独立相关（OR=0.141，95%CI：0.044 ~ 0.454，P=0.001）。结论 监测入院第1 周血脂动态变化有助于预测脓毒症休克患者短期预后。
Abstract:
Objective To explore the predictive value of blood lipid dynamics of septic shock for the short-term prognosis. Methods A total of 107 patients with septic shock treated in Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine from March 2019 to July 2023 were selected as the study subjects. They were divided into survival group (n=76) and death group (n=31) based on their 28-day outcomes. Total cholesterol (TC), triacylglycerol (TG), high density lipoprotein cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrations were tested at disease onset (day 0), day 4±1 and day 7±1. The receiver operating characteristic (ROC) curve was used to analyze the predictive value of lipid dynamics on outcomes in patients with septic shock. Multivariate COX regression analysis was used to analyze factors affecting the prognosis of patients with septic shock. Result The levels of TC and HDL-C at disease onset, as well as TC, HDL-C and LDL-C on day (4±1) and day (7±1) in the survival group were higher than those in death group, and the differences were significant (Z=2.241~ 5.744, all P<0.05). The areas under the curve [AUC(95%)] for the prediction of changes in HDL-C and LDL-C in the first week of admission were 0.775 (95%CI: 0.685 ~ 0.850) and 0.646 (95%CI: 0.547 ~ 0.736), with the best cutoff values of 0.16mmol/L and 0.28mmol/L, sensitivity of 70.97% and 64.52%, and specificity of 82.89% and 69.74%, respectively. Multivariate regression analysis showed that HDL-C dynamics was independently associated with poor prognosis (OR=0.141, 95%CI: 0.044 ~ 0.454, P=0.001). Conclusion Monitoring the dynamic changes of blood lipid at the first week of admission could help in predicting short-term outcomes in patients with septic shock.

参考文献/References:

[1] SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[2] 张晨, 孙虹佳. 新型感染标志物在脓毒症早期诊断中的应用及研究进展[J]. 现代检验医学杂志, 2021,36(1): 156-160. ZHANG Chen, SUN Hongjia. Latest research progress of early serum inflammatory and oxidative stress mediator of sepsis[J]. Journal of Modern Laboratory Medicine, 2021, 36(1): 156-160.
[3] APPIAH M G, PARK E J, AKAMA Y, et al. Cellular and exosomal regulations of sepsis-induced metabolic alterations[J]. International Journal of Molecular Sciences, 2021, 22(15): 8295.
[4] LIU Jingjing, ZHOU Gaosheng, WANG Xiaoting, et al. Metabolic reprogramming consequences of sepsis: adaptations and contradictions[J]. Cellular and Molecular Life Sciences, 2022, 79(8): 456.
[5] 梁群, 薛鸿征, 冯文佳. 脂蛋白在脓毒症中作用的研究进展[J]. 中国急救医学, 2021, 41（8): 729-733. LIANG Qun, XUE Hongzheng, FENG Wenjia. Advances in the role of lipoproteins in sepsis[J]. Chinese Journal of Critical Care Medicine, 2021, 41(8): 729-733.
[6] LEVELS J H, LEMAIRE L C, VAN DEN ENDE A E, et al. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure[J]. Critical Care Medicine, 2003, 31(6): 1647-1653.
[7] KHALIQ W, GRO?MANN P, NEUGEBAUER S, et al. Lipid metabolic signatures deviate in sepsis survivors compared to non-survivors[J]. Computational and Structural Biotechnology Journal, 2020, 18: 3678-3691.
[8] CHENG Long, ZHANG Feng, XUE Wenjing, et al. Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0[J]. Cardiovascular Diabetology, 2023, 22(1): 142.
[9] JOFFRE J, HELLMAN J. Oxidative stress and endothel ial dysfunct ion in sepsis and acute inflammation[J]. Antioxidants & Redox Signaling, 2021, 35(15): 1291-1307.
[10] BEHLING-KELLY E, HAAK C E, CARNEY P, et al. Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome[J]. Journal of Veterinary Internal Medicine, 2022, 36(3): 993-1004.
[11] DE GEEST B, MISHRA M. Impact of high-density lipoproteins on sepsis[J]. International Journal of Molecular Sciences, 2022, 23(21): 12965.
[12] MAILE M D, SIGAKIS M J, STRINGER K A, et al. Impact of the pre-illness lipid profile on sepsis mortality[J]. Journal of Critical Care, 2020, 57: 197-202.
[13] TRINDER M, WALLEY K R, BOYD J H, et al. Causal inference for genetically determined levels of highdensity lipoprotein cholesterol and risk of infectious disease[J]. Arteriosclerosis Thrombosis and Vascular Biology, 2020, 40(1): 267-278.
[14] TANAKA S, GEN?VE C, ZAPPELLA N, et al. Reconstituted high-density lipoprotein therapy improves survival in mouse models of sepsis[J]. Anesthesiology, 2020, 132(4): 825-838.
[15] CHAGU? C, GAUTIER T, DAL ZUFFO L, et al. High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation[J]. American Journal of Transplantation, 2022, 22(5): 1350-1361.

相似文献/References:

[1]陈丽华a,王思思b,朱婕曼a,等.高龄产妇孕中期血清 FPG，HbA1c 及 TC 联合检测预测 GDM 风险的临床研究[J].现代检验医学杂志,2020,35(06):33.[doi:doi:10.3969/j.issn.1671-7414.2020.06.009]
　CHEN Li-hua a,WANGg Si-si b,ZHU Jie-man a,et al.Clinical Study on Prediction of GDM Risk by Combined Detection of SerumFPG, HbA1c and TC in the Second Trimester of Pregnancy in Elderly Women[J].Journal of Modern Laboratory Medicine,2020,35(04):33.[doi:doi:10.3969/j.issn.1671-7414.2020.06.009]

备注/Memo

备注/Memo:
作者简介：张士跃(1977-)，男，副主任技师，研究方向：临床生物化学，E-mail：liuchunlai 520@126.com。
通讯作者：齐兴，E-mail：myqx1990@163.com。
更新日期/Last Update: 2024-07-15